Emergence of Preexisting MET Y1230C Mutation as a Resistance Mechanism to Crizotinib in NSCLC with MET Exon 14 Skipping-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Emergence of Preexisting MET Y1230C Mutation as a Resistance Mechanism to Crizotinib in NSCLC with MET Exon 14 Skipping

Published:2017-01 Issue:1 Volume:12 Page:137-140
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Ou Sai-Hong Ignatius,Young Lauren,Schrock Alexa B.,Johnson Adrienne,Klempner Samuel J.,Zhu Viola W.,Miller Vincent A.,Ali Siraj M.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference16 articles.

1. cMET exon 14 skipping: from the structure to the clinic;Van Der Steen;J Thorac Oncol,2016

2. Efficacy and safety of crizotinib in patients (pts) with advanced MET exon 14-altered non-small cell lung cancer (NSCLC);Drilon;J Clin Oncol,2016

3. Acquired resistance to crizotinib in NSCLC with MET exon 14 skipping;Heist;J Thorac Oncol,2016

4. Targeting receptor tyrosine kinase MET in cancer: small molecule inhibitors and clinical progress;Cui;J Med Chem,2014

5. Multiple mutations and bypass mechanisms can contribute to development of acquired resistance to MET inhibitors;Qi;Cancer Res,2011

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mutation of MET D1228N as an Acquired Potential Mechanism of Crizotinib Resistance in NSCLC with MET Y1003H Mutation;Lung Cancer: Targets and Therapy;2024-08

2. Unlocking the potential of bispecific ADCs for targeted cancer therapy;Frontiers of Medicine;2024-07-23

3. Recording and classifying MET receptor mutations in cancers;eLife;2024-04-23

4. Case report: Acquired resistance to crizotinib from a MET Y1230H mutation in a patient with non-small cell lung cancer and KIF5B-MET fusion;Frontiers in Oncology;2024-04-16

5. Screening Ultra-Large Encoded Compound Libraries Leads to Novel Protein–Ligand Interactions and High Selectivity;Journal of Medicinal Chemistry;2024-01-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3